ĢƵ

close

TAGGED : clinical trials

Bupa UK to cover EpiSwitch® CiRT for customers with cancer

OXFORD, England--(BUSINESS WIRE)--Oct 18, 2023--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform and Bupa, the UKĢƵ leading health insurer, announce a strategic agreement to give Bupa ...